Smoking Cessation • August 30, 2026
Johns Hopkins Tobacco Cessation Protocol: 80% Abstinence at 6 Months
Johns Hopkins clinical trial reported an unmatched 80% biological verification of smoking abstinence at 6 months post-psilocybin treatment.
The Highest Success Rate in Nicotine Addiction Research
Current nicotine replacement therapy and Chantix exhibit 6-month success rates between 20% and 35%. Johns Hopkins tested 15 treatment-resistant smokers with psilocybin.
80% Biologically Verified Abstinence Rate
Carbon monoxide and urinary cotinine testing confirmed that 80% of participants remained completely smoke-free at 6 months, and 67% remained abstinent at 12 months.